Glaxosmithkline plc Share Price

Glaxosmithkline plc competes in the Manufacturing sector and Pharmaceutical Preparation Manufacturing industry. It is headquartered in Brentford, United Kingdom and is traded on the London Stock Exchange, through the symbol GSK-LN.

GBX£1,677.80
0.53%
Previous Close:
GBX£16.69 -0.0043% (February 19th, 2024)

Latest Share Trading Activity for Glaxosmithkline plc

Day Open:
GBX£1,669.00(previous open GBX£16.76)
Day High:
GBX£1,685.00(previous high GBX£16.80)
Day Low:
GBX£1,655.23(previous low GBX£16.59)

About Glaxosmithkline plc

Company Description
we are a science-led global healthcare company that researches and develops a broad range of innovative products in three primary areas of pharmaceuticals, vaccines and consumer healthcare. as one of the few healthcare companies researching both medicines and vaccines for the world health organization’s three priority diseases – hiv/aids, tuberculosis and malaria, we are very proud to have developed some of the leading global medicines in these fields. our product portfolio also includes a range of consumer brands, many of which are household names around the world, including sensodyne, aquafresh, horlicks, panadol and tums.
Chief Executive Officer (CEO)
Emma Walmsley
Website Address
https://www.gsk.com/
Postal Address
G S K House 980 Great West Road Middlesex Brentford United Kingdom
Phone Number

Glaxosmithkline plc Historic Prices and Volume

CurrencyGBP
Issue CountryGB
52 Week Range£12.76 - £16.81
52 Week Change£0.17
50 Day Moving Average£15.85
200 Day Moving Average£14.66
Average 10 Day Volume9765134
Average 30 Day Volume10185994
5 Day % Change1%
30 Day % Change7%
3 Month % Change19%
6 Month % Change26%
1 Year % Change17%
2 Year % Change15%
5 Year % Change34%
Year To Date % Change16%

© 2024 shareprice.ie

While Shareprice.ie does what we can to maintain the high quality of the information displayed on this site, we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.